1. Aflibercept: risk of osteonecrosis of the jaw

   News item 02 April 2016 Pages: 1 - 1

2. FDA warning of opioid interaction with serotonergics

   News item 02 April 2016 Pages: 2 - 2

3. Health Canada halts Zydelig trials due to serious AEs

   News item 02 April 2016 Pages: 3 - 3

4. Inhaled corticosteroids increase risk of pneumonia in COPD

   News item 02 April 2016 Pages: 4 - 4

5. Japan's PMDA releases investigation results for 8 products

   News item 02 April 2016 Pages: 5 - 5

6. No new safety issues with Bexsero reported to TGA

   News item 02 April 2016 Pages: 6 - 6

7. Possible hepatitis B reactivation with direct-acting antivirals

   News item 02 April 2016 Pages: 7 - 7

8. PRAC issues provisional safety recommendations for Zydelig

   News item 02 April 2016 Pages: 8 - 8

9. CAM often used but not disclosed to primary care physicians

   Clinical study 02 April 2016 Pages: 9 - 9

10. COGENT advice: use prophylactic PPIs with DAPT

    Clinical study 02 April 2016 Pages: 10 - 10

11. Financial incentives reduce high-risk prescribing and hospitalisation

    Clinical study 02 April 2016 Pages: 11 - 11

12. No increased risk of CV events with long-term antidepressants

    Clinical study 02 April 2016 Pages: 12 - 12

13. Pretreatment genotyping cost effective for some drugs

    Clinical study 02 April 2016 Pages: 13 - 13

14. Abiraterone acetate

    Case report 02 April 2016 Pages: 14 - 14

15. Adalimumab/certolizumab-pegol/infliximab

    Case report 02 April 2016 Pages: 15 - 15

16. Adalimumab/etanercept/ustekinumab

    Case report 02 April 2016 Pages: 16 - 16

17. Adefovir dipivoxil

    Case report 02 April 2016 Pages: 17 - 17

18. Adenosine

    Case report 02 April 2016 Pages: 18 - 18

19. Afatinib

    Case report 02 April 2016 Pages: 19 - 19

20. Afatinib

    Case report 02 April 2016 Pages: 20 - 20

21. Albendazole

    Case report 02 April 2016 Pages: 21 - 21

22. Amezinium-metilsulfate

    Case report 02 April 2016 Pages: 22 - 22

23. Amfetamine abuse

    Case report 02 April 2016 Pages: 23 - 23

24. Amitriptyline overdose

    Case report 02 April 2016 Pages: 24 - 24

25. Amlodipine/bicalutamide

    Case report 02 April 2016 Pages: 25 - 25

26. Amoxicillin/clavulanic-acid

    Case report 02 April 2016 Pages: 26 - 26

27. Amrubicin

    Case report 02 April 2016 Pages: 27 - 27

28. Antineoplastics

    Case report 02 April 2016 Pages: 28 - 28

29. Antineoplastics

    Case report 02 April 2016 Pages: 29 - 29

30. Antineoplastics

    Case report 02 April 2016 Pages: 30 - 30

31. Antineoplastics

    Case report 02 April 2016 Pages: 31 - 31

32. Aripiprazole/risperidone

    Case report 02 April 2016 Pages: 32 - 32

33. Aspirin/caffeine/diclofenac/paracetamolabuse

    Case report 02 April 2016 Pages: 33 - 33

34. Aspirin/sulfasalazine

    Case report 02 April 2016 Pages: 34 - 34

35. Atovaquone/proguanil

    Case report 02 April 2016 Pages: 35 - 35

36. Azacitidine

    Case report 02 April 2016 Pages: 36 - 36

37. Azathioprine

    Case report 02 April 2016 Pages: 37 - 37

38. Belatacept

    Case report 02 April 2016 Pages: 38 - 38

39. Bendamustine

    Case report 02 April 2016 Pages: 39 - 39

40. Bevacizumab

    Case report 02 April 2016 Pages: 40 - 40

41. Bevacizumab/capecitabine/oxaliplatin

    Case report 02 April 2016 Pages: 41 - 41

42. Bortezomib

    Case report 02 April 2016 Pages: 42 - 42

43. Bumetanide/levodopa

    Case report 02 April 2016 Pages: 43 - 43

44. Bupivacaine

    Case report 02 April 2016 Pages: 44 - 44

45. Bupivacaine

    Case report 02 April 2016 Pages: 45 - 45

46. Bupivacaine

    Case report 02 April 2016 Pages: 46 - 46

47. Bupivacaine/fentanyl

    Case report 02 April 2016 Pages: 47 - 47

48. Bupivacaine/ropivacaine

    Case report 02 April 2016 Pages: 48 - 48

49. Camphor

    Case report 02 April 2016 Pages: 49 - 49

50. Capecitabine

    Case report 02 April 2016 Pages: 50 - 50